Hyperlipemia Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SYH2053 in Subjects With Normal or Elevated Low-Density Lipoprotein Cholesterol
This is a randomized, double-blind, placebo-controlled, single ascending dose (SAD) study of SYH2053 when administered subcutaneously to subjects with normal and elevated LDL-C.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04382521 -
A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions
|
N/A | |
| Not yet recruiting |
NCT02593487 -
Effect of Rosuvastatin Therapy on HDL2 Level
|
Phase 4 | |
| Active, not recruiting |
NCT02697422 -
Veteran Peer Coaches Optimizing and Advancing Cardiac Health
|
N/A | |
| Completed |
NCT04469673 -
A Study to Evaluate the Safety, Tolerability and Efficacy of Multiple Doses of JS002 in Patients With Hyperlipidemia..
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05912296 -
A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD7022
|
Phase 1 | |
| Active, not recruiting |
NCT05432544 -
Safety and Tolerability of SHR-1918 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03950752 -
Effect of Consumption of Bagel Without Palm Oil on Postprandial Lipidemia
|
N/A | |
| Completed |
NCT05532800 -
The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia
|
Phase 3 | |
| Completed |
NCT04781114 -
The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia
|
Phase 3 | |
| Active, not recruiting |
NCT04515927 -
To Evaluate the Efficacy and Safety of JS002 in HoFH Patients
|
Phase 2 |